Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy

What this episode covers

Visit https://www.peervoice.com/NEX860 to view the entire programme with slides. After completing “Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy”, participants will be able to: Outline the role of Gd-IgA1 and specific immune-mediated mechanisms in the pathophysiology of IgA nephropathy (IgAN); Summarize the relationship between key predictors of long-term outcome and their role in assessing risk of progression in patients with IgAN; Describe the role of different immune-specific targets in IgAN; and Evaluate clinical data regarding therapies targeting immune-specific mediators of disease in patients with IgAN.

Distinct summary based on available episode metadata or transcript content.